ArticleJournal for immunotherapy of cancer2025

Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma.

Pengpeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.